#United States #Class Action #Kessler Topaz #Radnor, PA #Applied Therapeutics

Investors Alert: Class Action Against Applied Therapeutics

The prominent law firm Kessler Topaz Meltzer & Check, LLP has issued a critical reminder for investors in Applied Therapeutics, Inc. regarding a securities fraud class action lawsuit. This lawsuit has been officially filed in the United States District Court for the Southern District of New York. It aims to hold the company accountable for allegations that may have led to significant financial loss among its investors.

Background of the Lawsuit

The class action involves investors who purchased or acquired shares of Applied Therapeutics securities during the designated period from January 3, 2024, to December 2, 2024. Allegations state that company officials misled investors regarding the clinical trial protocols for their drug candidate, govorestat. The lawsuit highlights concerns that their improper adherence to established clinical practices posed a substantial risk to the acceptance of trial data by the FDA.

Lead plaintiff applications must be submitted by February 18, 2025, allowing affected investors the opportunity to become a class representative, guiding the litigation process.

Details on the Allegations

The complaint clarifies the key issues surrounding the misconduct of Applied Therapeutics, stating that numerous false statements were made during the class period. These misstatements potentially misled investors about the viability of govorestat, directly impacting stock valuations and investor confidence.

Kessler Topaz Meltzer & Check, LLP is encouraging all investors who believe they suffered losses connected to these activities to reach out for guidance on involvement in the ongoing class action. Joining as a lead plaintiff provides a significant opportunity to influence the proceedings, although it is not necessary for recovery if one chooses not to serve in this role.

How to Participate

If you have incurred financial losses related to your investment in Applied Therapeutics, you are urged to contact the law firm. Further details about the processes involved in becoming a lead plaintiff, as well as other necessary actions that can be taken, are readily accessible. Interested parties can use the following link to initiate their participation or to seek additional information.

About Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP has established a reputable track record of handling class action lawsuits across multiple jurisdictions. The firm prides itself on its commitment to protecting investors' rights against corporate misconduct. Legal expert Jonathan Naji can be reached directly for personalized assistance relating to this matter.

Investors are encouraged to act swiftly, as the deadline to join the class action is fast approaching. Protect your financial interests by staying informed and seeking expert legal guidance!

Conclusion

For anyone who purchased shares in Applied Therapeutics within the mentioned timeframe, taking action is essential to ensure that you maintain your rights. Don’t delay; reach out to Kessler Topaz Meltzer & Check, LLP today.

• ---